ECM
AGN

Estabrook Capital Management’s Allergan plc AGN Stock Holding History

Estabrook Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-158
Closed -$23.1K – 331
2019
Q1 		$23.1K Hold
158
– – ﹤0.01% 258
2018
Q4 		$21.1K Sell
158
-49
-24% -$8.03K ﹤0.01% 255
2018
Q3 		$39.4K Hold
207
– – 0.01% 230
2018
Q2 		$34.5K Sell
207
-370
-64% -$59.4K 0.01% 243
2018
Q1 		$97.1K Buy
+577
New +$96.8K 0.02% 174
2015
Q3 		– Sell
-69
Closed -$20.9K – 473
2015
Q2 		$20.9K Hold
69
– – ﹤0.01% 314
2015
Q1 		$20.5K Sell
69
-20
-22% -$5.7K ﹤0.01% 328
2014
Q4 		$22.9K Hold
89
– – ﹤0.01% 329
2014
Q3 		$21.5K Buy
+89
New +$19.9K ﹤0.01% 333

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Estabrook Capital Management's AGN Position: Q2 2019 in Review

Estabrook Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 158 shares — an estimated $23.1K sold.

Estabrook Capital Management first reported a position in AGN in Q3 2014 and held it in 9 quarters. The position peaked at $97.1K in Q1 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Estabrook Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Estabrook Capital Management sold 158 Allergan plc shares in Q2 2019, an estimated $23.1K.
  • Estabrook Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 9 quarters.
  • Estabrook Capital Management's Allergan plc position peaked at $97.1K in Q1 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Estabrook Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.